Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia
Authors:
- Matthew R. BanMBMatthew R. Ban
- Robert A. HegeleRHRobert A. Hegele
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 46 (2) , 366-372
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse LiverJournal of Biological Chemistry, 2004
- Family cancer histories predictive of a high risk of hereditary non‐polyposis colorectal cancer associate significantly with a genomic rearrangement in hMSH2 or hMLH1Clinical Genetics, 2004
- Monogenic hypercholesterolemia: new insights in pathogenesis and treatmentJournal of Clinical Investigation, 2003
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemiaAtherosclerosis, 2003
- Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificationNucleic Acids Research, 2002
- Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descentHuman Mutation, 2001
- Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor ProteinScience, 2001
- The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100Journal of Biological Chemistry, 2001
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999